Ana Carolina da Silva Almeida

Ana Carolina da Silva Almeida, PhD, is a Principal Scientist at Biogen since April 2018, leading drug discovery initiatives in the Biologics Drug Discovery department focused on Neurodegeneration and Immunology. Previously, Ana served as a Senior Scientist at Pfizer and held multiple positions at Columbia University Medical Center, contributing to significant research in neuro-inflammation and T-cell biology. Ana's early career included roles as a Research Scientist at DDF Drug Discovery Factory and a Ph.D. Fellow at Universitair Medisch Centrum Utrecht, with accomplishments in drug screening and molecular biology. Ana earned a Post-Doctorate from Columbia University, a Ph.D. from Utrecht University, and an M.Sc. from Universidade do Porto.